SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-23-000116
Filing Date
2023-12-18
Accepted
2023-12-18 16:32:22
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1702935129.html 4  
1 FORM 4 wk-form4_1702935129.xml 4 3512
  Complete submission text file 0001479290-23-000116.txt   4951
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560
Business Address
Sjuts Dustin S (Reporting) CIK: 0001796224 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 231494222